MADE POSSIBLE BY:
MADE POSSIBLE BY:
Home Tags SMARTag® bioconjugation technology

Tag: SMARTag® bioconjugation technology

Triphase’s TRPH-222 enters Clinical Phase I trials

Triphase Accelerator’s TRPH-222, an anti-CD22 antibody-drug conjugate (ADC) for the treatment of patients with lymphoma, has been dosed in the first patient in a...